- REPORT SUMMARY
- TABLE OF CONTENTS
-
The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
Automation in Biopharmaceutical market report explains the definition, types, applications, major countries, and major players of the Automation in Biopharmaceutical market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
RheoSense
BioProcess International
Danaher
Eirechrom
Novasep
Tecan Trading
Capsugel
Waters
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
GE
PerkinElmer
By Type:
Clinical stage automation
Drug discovery stage automation
By End-User:
Research and Development
Clinical
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Automation in Biopharmaceutical Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Automation in Biopharmaceutical Outlook to 2028- Original Forecasts
-
2.2 Automation in Biopharmaceutical Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Automation in Biopharmaceutical Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Automation in Biopharmaceutical Market- Recent Developments
-
6.1 Automation in Biopharmaceutical Market News and Developments
-
6.2 Automation in Biopharmaceutical Market Deals Landscape
7 Automation in Biopharmaceutical Raw Materials and Cost Structure Analysis
-
7.1 Automation in Biopharmaceutical Key Raw Materials
-
7.2 Automation in Biopharmaceutical Price Trend of Key Raw Materials
-
7.3 Automation in Biopharmaceutical Key Suppliers of Raw Materials
-
7.4 Automation in Biopharmaceutical Market Concentration Rate of Raw Materials
-
7.5 Automation in Biopharmaceutical Cost Structure Analysis
-
7.5.1 Automation in Biopharmaceutical Raw Materials Analysis
-
7.5.2 Automation in Biopharmaceutical Labor Cost Analysis
-
7.5.3 Automation in Biopharmaceutical Manufacturing Expenses Analysis
8 Global Automation in Biopharmaceutical Import and Export Analysis (Top 10 Countries)
-
8.1 Global Automation in Biopharmaceutical Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Automation in Biopharmaceutical Export by Region (Top 10 Countries) (2017-2028)
9 Global Automation in Biopharmaceutical Market Outlook by Types and Applications to 2022
-
9.1 Global Automation in Biopharmaceutical Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Clinical stage automation Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Drug discovery stage automation Consumption and Growth Rate (2017-2022)
-
9.2 Global Automation in Biopharmaceutical Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research and Development Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinical Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Automation in Biopharmaceutical Market Analysis and Outlook till 2022
-
10.1 Global Automation in Biopharmaceutical Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Automation in Biopharmaceutical Consumption (2017-2022)
-
10.2.2 Canada Automation in Biopharmaceutical Consumption (2017-2022)
-
10.2.3 Mexico Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.2 UK Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.3 Spain Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.4 Belgium Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.5 France Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.6 Italy Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.7 Denmark Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.8 Finland Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.9 Norway Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.10 Sweden Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.11 Poland Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.12 Russia Automation in Biopharmaceutical Consumption (2017-2022)
-
10.3.13 Turkey Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.2 Japan Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.3 India Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.4 South Korea Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.5 Pakistan Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.6 Bangladesh Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.7 Indonesia Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.8 Thailand Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.9 Singapore Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.10 Malaysia Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.11 Philippines Automation in Biopharmaceutical Consumption (2017-2022)
-
10.4.12 Vietnam Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.2 Colombia Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.3 Chile Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.4 Argentina Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.5 Venezuela Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.6 Peru Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.7 Puerto Rico Automation in Biopharmaceutical Consumption (2017-2022)
-
10.5.8 Ecuador Automation in Biopharmaceutical Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Automation in Biopharmaceutical Consumption (2017-2022)
-
10.6.2 Kuwait Automation in Biopharmaceutical Consumption (2017-2022)
-
10.6.3 Oman Automation in Biopharmaceutical Consumption (2017-2022)
-
10.6.4 Qatar Automation in Biopharmaceutical Consumption (2017-2022)
-
10.6.5 Saudi Arabia Automation in Biopharmaceutical Consumption (2017-2022)
-
10.6.6 United Arab Emirates Automation in Biopharmaceutical Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Automation in Biopharmaceutical Consumption (2017-2022)
-
10.7.2 South Africa Automation in Biopharmaceutical Consumption (2017-2022)
-
10.7.3 Egypt Automation in Biopharmaceutical Consumption (2017-2022)
-
10.7.4 Algeria Automation in Biopharmaceutical Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Automation in Biopharmaceutical Consumption (2017-2022)
-
10.8.2 New Zealand Automation in Biopharmaceutical Consumption (2017-2022)
11 Global Automation in Biopharmaceutical Competitive Analysis
-
11.1 RheoSense
-
11.1.1 RheoSense Company Details
-
11.1.2 RheoSense Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 RheoSense Automation in Biopharmaceutical Main Business and Markets Served
-
11.1.4 RheoSense Automation in Biopharmaceutical Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 BioProcess International
-
11.2.1 BioProcess International Company Details
-
11.2.2 BioProcess International Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 BioProcess International Automation in Biopharmaceutical Main Business and Markets Served
-
11.2.4 BioProcess International Automation in Biopharmaceutical Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Danaher
-
11.3.1 Danaher Company Details
-
11.3.2 Danaher Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Danaher Automation in Biopharmaceutical Main Business and Markets Served
-
11.3.4 Danaher Automation in Biopharmaceutical Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eirechrom
-
11.4.1 Eirechrom Company Details
-
11.4.2 Eirechrom Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eirechrom Automation in Biopharmaceutical Main Business and Markets Served
-
11.4.4 Eirechrom Automation in Biopharmaceutical Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novasep
-
11.5.1 Novasep Company Details
-
11.5.2 Novasep Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novasep Automation in Biopharmaceutical Main Business and Markets Served
-
11.5.4 Novasep Automation in Biopharmaceutical Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Tecan Trading
-
11.6.1 Tecan Trading Company Details
-
11.6.2 Tecan Trading Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Tecan Trading Automation in Biopharmaceutical Main Business and Markets Served
-
11.6.4 Tecan Trading Automation in Biopharmaceutical Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Capsugel
-
11.7.1 Capsugel Company Details
-
11.7.2 Capsugel Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Capsugel Automation in Biopharmaceutical Main Business and Markets Served
-
11.7.4 Capsugel Automation in Biopharmaceutical Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Waters
-
11.8.1 Waters Company Details
-
11.8.2 Waters Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Waters Automation in Biopharmaceutical Main Business and Markets Served
-
11.8.4 Waters Automation in Biopharmaceutical Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Thermo Fisher Scientific
-
11.9.1 Thermo Fisher Scientific Company Details
-
11.9.2 Thermo Fisher Scientific Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Thermo Fisher Scientific Automation in Biopharmaceutical Main Business and Markets Served
-
11.9.4 Thermo Fisher Scientific Automation in Biopharmaceutical Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Bruker
-
11.10.1 Bruker Company Details
-
11.10.2 Bruker Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Bruker Automation in Biopharmaceutical Main Business and Markets Served
-
11.10.4 Bruker Automation in Biopharmaceutical Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Peak Analysis & Automation
-
11.11.1 Peak Analysis & Automation Company Details
-
11.11.2 Peak Analysis & Automation Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Peak Analysis & Automation Automation in Biopharmaceutical Main Business and Markets Served
-
11.11.4 Peak Analysis & Automation Automation in Biopharmaceutical Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 GE
-
11.12.1 GE Company Details
-
11.12.2 GE Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 GE Automation in Biopharmaceutical Main Business and Markets Served
-
11.12.4 GE Automation in Biopharmaceutical Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 PerkinElmer
-
11.13.1 PerkinElmer Company Details
-
11.13.2 PerkinElmer Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 PerkinElmer Automation in Biopharmaceutical Main Business and Markets Served
-
11.13.4 PerkinElmer Automation in Biopharmaceutical Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Automation in Biopharmaceutical Market Outlook by Types and Applications to 2028
-
12.1 Global Automation in Biopharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Clinical stage automation Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Drug discovery stage automation Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Automation in Biopharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Research and Development Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinical Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Automation in Biopharmaceutical Market Analysis and Outlook to 2028
-
13.1 Global Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.2.2 Canada Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.2.3 Mexico Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.2 UK Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.3 Spain Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.4 Belgium Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.5 France Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.6 Italy Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.7 Denmark Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.8 Finland Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.9 Norway Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.10 Sweden Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.11 Poland Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.12 Russia Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.3.13 Turkey Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.2 Japan Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.3 India Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.4 South Korea Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.8 Thailand Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.9 Singapore Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.11 Philippines Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.2 Colombia Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.3 Chile Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.4 Argentina Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.6 Peru Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.6.3 Oman Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.6.4 Qatar Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.7.2 South Africa Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.7.3 Egypt Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.7.4 Algeria Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Automation in Biopharmaceutical Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Automation in Biopharmaceutical Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Automation in Biopharmaceutical
-
Figure of Automation in Biopharmaceutical Picture
-
Table Global Automation in Biopharmaceutical Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Automation in Biopharmaceutical Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Clinical stage automation Consumption and Growth Rate (2017-2022)
-
Figure Global Drug discovery stage automation Consumption and Growth Rate (2017-2022)
-
Figure Global Research and Development Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Consumption and Growth Rate (2017-2022)
-
Figure Global Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Table North America Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure United States Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Canada Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Mexico Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Europe Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure Germany Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure UK Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Spain Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Belgium Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure France Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Italy Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Denmark Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Finland Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Norway Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Sweden Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Poland Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Russia Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Turkey Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table APAC Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure China Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Japan Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure India Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure South Korea Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Thailand Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Singapore Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Philippines Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table South America Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure Brazil Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Colombia Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Chile Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Argentina Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Peru Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table GCC Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure Bahrain Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Oman Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Qatar Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Africa Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure Nigeria Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure South Africa Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Egypt Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Algeria Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Oceania Automation in Biopharmaceutical Consumption by Country (2017-2022)
-
Figure Australia Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Automation in Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Table RheoSense Company Details
-
Table RheoSense Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table RheoSense Automation in Biopharmaceutical Main Business and Markets Served
-
Table RheoSense Automation in Biopharmaceutical Product Portfolio
-
Table BioProcess International Company Details
-
Table BioProcess International Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioProcess International Automation in Biopharmaceutical Main Business and Markets Served
-
Table BioProcess International Automation in Biopharmaceutical Product Portfolio
-
Table Danaher Company Details
-
Table Danaher Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Automation in Biopharmaceutical Main Business and Markets Served
-
Table Danaher Automation in Biopharmaceutical Product Portfolio
-
Table Eirechrom Company Details
-
Table Eirechrom Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eirechrom Automation in Biopharmaceutical Main Business and Markets Served
-
Table Eirechrom Automation in Biopharmaceutical Product Portfolio
-
Table Novasep Company Details
-
Table Novasep Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novasep Automation in Biopharmaceutical Main Business and Markets Served
-
Table Novasep Automation in Biopharmaceutical Product Portfolio
-
Table Tecan Trading Company Details
-
Table Tecan Trading Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tecan Trading Automation in Biopharmaceutical Main Business and Markets Served
-
Table Tecan Trading Automation in Biopharmaceutical Product Portfolio
-
Table Capsugel Company Details
-
Table Capsugel Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Capsugel Automation in Biopharmaceutical Main Business and Markets Served
-
Table Capsugel Automation in Biopharmaceutical Product Portfolio
-
Table Waters Company Details
-
Table Waters Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Waters Automation in Biopharmaceutical Main Business and Markets Served
-
Table Waters Automation in Biopharmaceutical Product Portfolio
-
Table Thermo Fisher Scientific Company Details
-
Table Thermo Fisher Scientific Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Automation in Biopharmaceutical Main Business and Markets Served
-
Table Thermo Fisher Scientific Automation in Biopharmaceutical Product Portfolio
-
Table Bruker Company Details
-
Table Bruker Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bruker Automation in Biopharmaceutical Main Business and Markets Served
-
Table Bruker Automation in Biopharmaceutical Product Portfolio
-
Table Peak Analysis & Automation Company Details
-
Table Peak Analysis & Automation Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Peak Analysis & Automation Automation in Biopharmaceutical Main Business and Markets Served
-
Table Peak Analysis & Automation Automation in Biopharmaceutical Product Portfolio
-
Table GE Company Details
-
Table GE Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Automation in Biopharmaceutical Main Business and Markets Served
-
Table GE Automation in Biopharmaceutical Product Portfolio
-
Table PerkinElmer Company Details
-
Table PerkinElmer Automation in Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Automation in Biopharmaceutical Main Business and Markets Served
-
Table PerkinElmer Automation in Biopharmaceutical Product Portfolio
-
Figure Global Clinical stage automation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug discovery stage automation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research and Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Table North America Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure United States Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Germany Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure China Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Brazil Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Automation in Biopharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure Australia Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Automation in Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-

Chinese